Description:
Covers new developments in the field of neuro-aids in the haart (highly-active antiretroviral therapy) era presents specific information on special populations affected by neuro-aids disorders, including women, minorities, children, and the elderly explores medicolegal issues, including end-of-life issues specific to neuro-aids patients provides basic pathophysiology updates on topics such as viral evolution, chemokines, cerebrospinal fluid biomarkers, cell cycle proteins, and vaccines and neuro-aids